awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q24649618-0D5E4ABF-5241-4692-8157-F96A68919221
Q24649618-0D5E4ABF-5241-4692-8157-F96A68919221
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24649618-0D5E4ABF-5241-4692-8157-F96A68919221
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management
P2860
Q24649618-0D5E4ABF-5241-4692-8157-F96A68919221
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24649618-0D5E4ABF-5241-4692-8157-F96A68919221
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e042c6165749cd73cb380c5a4976917f89498201
P2860
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.